Technical Analysis for ALBT - Avalon GloboCare Corp.

Grade Last Price % Change Price Change
F 0.28 4.16% 0.01
ALBT closed up 4.16 percent on Wednesday, May 8, 2024, on 8 percent of normal volume.
Earnings due: May 20
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish 4.16%
Pocket Pivot Bullish Swing Setup 4.16%
Inside Day Range Contraction 4.16%
Wide Bands Range Expansion 4.16%

   Recent Intraday Alerts

Alert Time
Rose Above 20 DMA about 18 hours ago
10 DMA Support about 18 hours ago
Up 10% about 18 hours ago
Possible NR7 about 18 hours ago
Possible Inside Day about 18 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
Classification

Sector: Healthcare
Industry: Medical Care
Keywords: Medicine Clinical Medicine Immunotherapy Cell Therapy Exosome Bioproduction Vesicles

Is ALBT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.419
52 Week Low 0.2412
Average Volume 170,581
200-Day Moving Average 0.62
50-Day Moving Average 0.32
20-Day Moving Average 0.28
10-Day Moving Average 0.27
Average True Range 0.04
RSI (14) 46.52
ADX 15.83
+DI 16.20
-DI 13.43
Chandelier Exit (Long, 3 ATRs) 0.27
Chandelier Exit (Short, 3 ATRs) 0.35
Upper Bollinger Bands 0.33
Lower Bollinger Band 0.24
Percent B (%b) 0.45
BandWidth 32.01
MACD Line -0.02
MACD Signal Line -0.02
MACD Histogram 0.0015
Fundamentals Value
Market Cap 3.08 Million
Num Shares 11 Million
EPS -0.93
Price-to-Earnings (P/E) Ratio -0.30
Price-to-Sales 4.16
Price-to-Book 7.51
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.33
Resistance 3 (R3) 0.33 0.32 0.32
Resistance 2 (R2) 0.32 0.30 0.32 0.32
Resistance 1 (R1) 0.30 0.30 0.31 0.30 0.32
Pivot Point 0.28 0.28 0.29 0.28 0.28
Support 1 (S1) 0.26 0.27 0.27 0.26 0.24
Support 2 (S2) 0.25 0.26 0.25 0.24
Support 3 (S3) 0.23 0.25 0.24
Support 4 (S4) 0.23